Advanced Therapeutic Antibody Discovery with Multiplexed Screening
White Paper Nov 25, 2018
Antibody-based therapeutics are the fastest growing and most successful therapeutic modality for treating numerous diseases including cancer, autoimmune disorders and infectious disease.
Multiplexed high throughput screening has become an essential component in the discovery of therapeutic antibodies.
Download this whitepaper to learn:
• How to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens.
• How the Intellicyt® iQue Screener PLUS platform can be used to carry out high content assays to evaluate the effects of lead candidates in multiplexed cell based and secreted protein assays.
Related White Papers
Download this whitepaper to discover an automated workflow that can help you to preserve the viability of your biological samples.
READ MOREDownload this brochure to discover solutions that can enable you to uncover the true complexities of cancer at the single cell level.
READ MOREIn this whitepaper, find out about changes in the regulation of data management in the pharma space and how advanced informatics solutions can help to support the switch to digital data.
READ MORELike what you just read? You can find similar content on the communities below.
Analysis & Separations Cancer Research Cell Science Genomics Research Proteomics & Metabolomics Immunology & MicrobiologyTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
